Scopoderm: Uses, Dosage & Side Effects
A transdermal patch containing hyoscine (scopolamine) for the prevention of motion sickness symptoms including nausea, vomiting, and dizziness
Scopoderm (hyoscine/scopolamine) is a prescription transdermal patch used to prevent symptoms of motion sickness, including nausea, vomiting, and dizziness. The patch is applied behind the ear and delivers the active ingredient through the skin at a controlled rate for up to 72 hours. Hyoscine works by blocking muscarinic acetylcholine receptors in the vestibular system and vomiting center of the brain, which are responsible for the neural signals that trigger motion sickness. The patch should be applied the evening before travel or at least 5–6 hours before departure. Common side effects include dry mouth, drowsiness, and blurred vision. Scopoderm is contraindicated in patients with glaucoma and should be used with caution in elderly patients, those with liver or kidney impairment, and individuals with certain gastrointestinal conditions.
Quick Facts: Scopoderm
Key Takeaways
- Scopoderm is a transdermal patch that delivers hyoscine (scopolamine) through the skin to prevent motion sickness symptoms including nausea, vomiting, and vertigo during travel by boat, plane, train, or car.
- One patch provides up to 72 hours of continuous protection. It should be applied to clean, dry, hairless skin behind the ear at least 5–6 hours before travel or the evening before departure.
- The most common side effects are dry mouth, drowsiness, dizziness, and blurred near vision; these are related to the anticholinergic mechanism and typically resolve after patch removal.
- Scopoderm is contraindicated in patients with glaucoma and should not be used in children under 10 years of age. Special caution is required in elderly patients and those with liver or kidney impairment.
- Hands must be washed thoroughly after handling the patch to prevent accidental eye contact with the active ingredient, which can cause temporary blurred vision and dilated pupils.
What Is Scopoderm and What Is It Used For?
Scopoderm contains the active substance hyoscine, also known internationally as scopolamine. Hyoscine is a naturally occurring tropane alkaloid originally derived from plants of the Solanaceae family, including henbane (Hyoscyamus niger), deadly nightshade (Atropa belladonna), and jimsonweed (Datura stramonium). It belongs to a group of medications called anticholinergics, which work by blocking the action of the neurotransmitter acetylcholine at muscarinic receptors throughout the body. In the context of motion sickness prevention, Scopoderm is classified as an antiemetic — a medication that prevents nausea and vomiting.
Motion sickness (also called travel sickness or kinetosis) is a condition that occurs when the brain receives conflicting sensory signals from the eyes, inner ear (vestibular system), and proprioceptive receptors during movement. For example, when traveling by boat, the inner ear detects motion from the waves, but the eyes may see a stationary cabin interior. This sensory mismatch triggers a cascade of neural responses involving the vestibular nuclei, the chemoreceptor trigger zone, and the vomiting center (nucleus tractus solitarius) in the brainstem. These responses rely heavily on muscarinic cholinergic and histaminergic neurotransmission. Symptoms typically include nausea, vomiting, cold sweating, pallor, dizziness, and a general sense of malaise.
Hyoscine is considered the most effective single agent for the prevention of motion sickness, a position supported by decades of clinical research and confirmed in Cochrane systematic reviews. It exerts its antiemetic effect primarily by blocking muscarinic M1 and M3 receptors in the vestibular nuclei and the vomiting center of the medulla oblongata. By inhibiting acetylcholine signaling in these critical neural pathways, hyoscine effectively reduces the sensitivity of the vestibular apparatus to motion and dampens the emetic reflex arc, thereby preventing the symptoms of motion sickness before they occur.
The Scopoderm transdermal delivery system represents a significant pharmaceutical advance over oral formulations of hyoscine. The patch utilizes a reservoir-type design approximately 1.8 cm in diameter, containing 1.3 mg of hyoscine. An initial priming dose is released rapidly to establish therapeutic plasma concentrations, followed by a controlled delivery rate of approximately 5 micrograms per hour over the subsequent 72 hours. This steady-state delivery eliminates the peaks and troughs associated with oral dosing, which not only provides more consistent protection against motion sickness but also reduces the incidence and severity of anticholinergic side effects that can be dose-dependent.
Scopoderm is indicated for the prevention of motion sickness symptoms that may occur during travel by boat, aircraft, train, or car. It is designed for prophylactic use — meaning it should be applied before exposure to motion rather than after symptoms have already developed. The patch is approved for use in adults and children aged 10 years and older. It is particularly popular among cruise passengers, sailors, military personnel, and individuals who are prone to travel sickness on long journeys. Hyoscine is included on the World Health Organization’s Model List of Essential Medicines, underscoring its clinical importance in global healthcare.
Unlike oral antihistamines (such as meclizine or dimenhydrinate) that must be taken every few hours, Scopoderm provides continuous protection for up to 72 hours from a single application. The transdermal delivery system bypasses first-pass metabolism in the liver, resulting in more predictable drug levels. Additionally, because the drug is absorbed through the skin rather than the gastrointestinal tract, it remains effective even if the patient experiences vomiting — a significant advantage over oral preparations.
What Should You Know Before Using Scopoderm?
Contraindications
Before using Scopoderm, it is essential to understand the conditions under which this medication must not be used. Absolute contraindications include a known allergy or hypersensitivity to hyoscine (scopolamine) or any of the inactive ingredients contained in the patch system, and a current or previous diagnosis of narrow-angle glaucoma (also known as angle-closure glaucoma). Hyoscine can increase intraocular pressure by causing pupil dilation (mydriasis) and relaxation of the ciliary muscle, which can precipitate an acute glaucoma attack in susceptible individuals with narrow drainage angles in the eye.
Patients with known hypersensitivity to other anticholinergic substances should also exercise extreme caution, as cross-reactivity may occur. If you have ever experienced an adverse reaction to any medication in the belladonna alkaloid family, inform your healthcare provider before using Scopoderm. The patch contains several inactive ingredients including aluminized polyester film, crospovidone, isopropyl palmitate, light mineral oil, polyisobutylene, ethylene-vinyl acetate copolymer, and polyester, and allergic reactions to any of these components, while rare, are possible.
Warnings and Precautions
Several clinical conditions require careful consideration before using Scopoderm, and in some cases the patch may be unsuitable. You should consult your doctor before using this medication if you experience any of the following:
- Gastrointestinal obstruction: Symptoms such as excessive fullness, bloating, gas, abdominal pain, constipation, diarrhea, or vomiting may indicate a bowel obstruction (ileus). Hyoscine reduces gastrointestinal motility and can worsen these conditions by further slowing bowel function.
- Pyloric stenosis: A condition in which the outlet of the stomach is narrowed, potentially trapping food and causing vomiting. Anticholinergic agents can exacerbate this condition.
- Urinary retention or prostate enlargement: Hyoscine relaxes smooth muscle in the urinary tract and can make it more difficult to urinate, particularly in men with benign prostatic hyperplasia (BPH).
- Metabolic disorders, liver or kidney impairment: These conditions may affect the metabolism and elimination of hyoscine, potentially leading to higher blood levels and increased risk of adverse effects.
- Eye pain, blurred vision, or rainbow halos around lights: These symptoms may indicate undiagnosed narrow-angle glaucoma. An eye examination by an ophthalmologist should be performed before using Scopoderm.
- Epilepsy or seizure disorders: There have been reports of increased seizure frequency in patients with epilepsy using hyoscine. Close monitoring by a healthcare provider is recommended.
In rare cases, confusion and visual hallucinations have been reported during use of the Scopoderm patch. If you experience these symptoms, remove the patch immediately and contact your healthcare provider. Caution should also be exercised after removing the patch, as side effects may persist for up to 24 hours or longer due to continued absorption of residual drug from the skin.
The Scopoderm patch must be removed before undergoing any MRI (magnetic resonance imaging) scan or similar medical imaging procedure. The metallic components in the patch backing (aluminized polyester film) can cause burns during MRI and may also interfere with image quality. Inform your radiology team that you are wearing a transdermal patch.
Pregnancy and Breastfeeding
If you are pregnant, think you may be pregnant, are planning to become pregnant, or are breastfeeding, consult your doctor or pharmacist before using Scopoderm. The safety of hyoscine during pregnancy has not been adequately established in controlled clinical trials. Animal reproductive studies have not demonstrated clear evidence of teratogenicity, but as with all medications during pregnancy, Scopoderm should only be used when the potential benefit justifies the potential risk to the fetus. This is particularly relevant during the first trimester when organogenesis is occurring.
Hyoscine is excreted in breast milk in small quantities. Because anticholinergic drugs can suppress lactation and may cause drowsiness, irritability, or feeding difficulties in the nursing infant, breastfeeding mothers should consult their healthcare provider to weigh the benefits of continued breastfeeding against the risks of drug exposure. If Scopoderm is deemed necessary, monitoring the infant for signs of anticholinergic effects (drowsiness, dry mouth, feeding difficulties) is advisable.
Driving and Operating Machinery
Scopoderm can cause side effects that impair your ability to drive safely or operate machinery. These include drowsiness, dizziness, disorientation, confusion, and visual disturbances (blurred vision, difficulty focusing, dilated pupils). Do not drive a vehicle, operate heavy machinery, or engage in any activity requiring full mental alertness, clear vision, or quick reflexes while using Scopoderm. These effects may persist for up to 24 hours after patch removal. The combination of hyoscine with alcohol, sedatives, or other central nervous system depressants can significantly intensify these impairments.
Use in Children and Elderly Patients
Scopoderm should not be used in children under the age of 10 years due to limited clinical experience in this population. Children may be more sensitive to the anticholinergic effects of hyoscine, including paradoxical excitation (restlessness, agitation) rather than sedation. For children aged 10 years and older, the standard adult dose of one patch at a time is recommended, but parental supervision is advised to ensure proper application and to monitor for side effects.
Elderly patients may use Scopoderm at the standard adult dosage; however, they may be at increased risk for anticholinergic adverse effects including confusion, cognitive impairment, urinary retention, constipation, and dry mouth. The elderly population often has reduced hepatic and renal function, which may prolong the duration of drug effects. Close monitoring and careful risk-benefit assessment are recommended before prescribing Scopoderm to older adults, particularly those already taking other anticholinergic medications.
Do not consume alcohol while using the Scopoderm patch. Alcohol enhances the central nervous system depressant effects of hyoscine, significantly increasing the risk of drowsiness, dizziness, confusion, and impaired coordination. This combination can be particularly dangerous if operating vehicles or machinery.
How Does Scopoderm Interact with Other Drugs?
Hyoscine (scopolamine) can interact with a number of other medications, primarily through additive anticholinergic effects or through combined central nervous system depression. When two or more drugs with anticholinergic properties are used simultaneously, the cumulative anticholinergic burden can lead to a syndrome characterized by severe dry mouth, urinary retention, constipation, tachycardia, blurred vision, cognitive impairment, delirium, and in extreme cases, hyperthermia and cardiovascular collapse. This is particularly concerning in elderly patients, who are already more susceptible to anticholinergic side effects.
It is crucial to inform your doctor or pharmacist about all medications you are currently taking, have recently taken, or may be planning to take, including prescription medications, over-the-counter drugs, herbal supplements, and vitamins. The following table summarizes the most clinically significant drug interactions with Scopoderm:
| Drug Class | Examples | Effect of Interaction | Severity |
|---|---|---|---|
| Anticholinergic drugs | Atropine, ipratropium, tiotropium, oxybutynin | Additive anticholinergic effects: increased dry mouth, urinary retention, constipation, confusion | Major |
| Antihistamines | Diphenhydramine, promethazine, chlorpheniramine, hydroxyzine | Enhanced sedation and anticholinergic effects | Moderate |
| Tricyclic antidepressants | Amitriptyline, nortriptyline, imipramine, clomipramine | Increased anticholinergic burden, enhanced sedation, risk of delirium | Major |
| Anti-Parkinson medications | Biperiden, trihexyphenidyl, benztropine | Additive anticholinergic effects, risk of anticholinergic toxicity | Major |
| Antiarrhythmic drugs | Disopyramide, quinidine | Enhanced anticholinergic effects on the heart, potential for tachycardia | Moderate |
| Other antiemetics | Meclizine, dimenhydrinate, cyclizine | Additive sedation and anticholinergic effects | Moderate |
| Antiviral drugs | Amantadine | Increased anticholinergic effects (amantadine has mild anticholinergic activity) | Moderate |
| CNS depressants | Benzodiazepines, opioids, alcohol, barbiturates | Enhanced sedation, respiratory depression, psychomotor impairment | Major |
In addition to pharmacological interactions, hyoscine may affect the absorption of other drugs from the gastrointestinal tract. Because anticholinergic agents reduce gastric motility and delay gastric emptying, the absorption rate of orally administered co-medications may be altered. This is typically not clinically significant for most drugs, but for medications with narrow therapeutic windows (such as digoxin, levothyroxine, or certain antibiotics), any change in absorption kinetics could potentially affect therapeutic outcomes.
Patients taking potassium chloride supplements in slow-release tablet form should be aware that anticholinergic agents can increase the contact time of these tablets with the gastrointestinal mucosa, potentially increasing the risk of local ulceration. If you are taking potassium supplements, discuss alternative formulations (liquid or effervescent) with your pharmacist.
The concept of “anticholinergic burden” refers to the cumulative effect of taking multiple medications with anticholinergic properties. Many commonly prescribed medications in older adults have anticholinergic effects, including some antihypertensives, antidepressants, bladder medications, and antihistamines. Adding Scopoderm to an existing regimen of medications with anticholinergic properties can tip the balance toward clinically significant toxicity, manifesting as delirium, falls, cognitive decline, and hospitalization. Healthcare providers should perform a thorough medication review before prescribing Scopoderm to elderly patients.
What Is the Correct Dosage of Scopoderm?
Always use Scopoderm exactly as prescribed by your doctor or as directed in the patient information leaflet. If you are unsure about any aspect of the application process, consult your doctor or pharmacist before applying the patch. The recommended dosage regimen is straightforward but requires attention to proper application technique for optimal effectiveness.
Adults
Standard Adult Dose
Apply one patch to a clean, dry, and hairless area of skin behind the ear (on the hairless area of the mastoid bone). Apply the patch the evening before travel or at least 5–6 hours before departure to allow sufficient time for the drug to reach therapeutic plasma levels. One patch provides protection for up to 72 hours (3 days).
Application instructions:
- Prepare the patch: Cut along the dotted line on the sachet and remove the beige patch complete with the transparent square protective film.
- Remove the protective film: Hold the patch by its edge and peel away the square transparent backing without touching the silver adhesive side of the patch.
- Apply the patch: Press the silver adhesive side firmly onto clean, dry, hairless skin behind the ear. Ensure the patch is securely attached. Once in place, do not reposition the patch.
- Wash your hands: After applying or removing the patch, wash your hands thoroughly with soap and water. After removal, also wash the application site. This prevents traces of hyoscine from being transferred from your fingers to your eyes, which can cause temporary blurred near vision and dilated pupils (sometimes in only one eye).
If the patch accidentally falls off during use, discard it and replace it with a new one applied to a fresh site behind the ear. If protection is needed for more than 72 hours, remove the used patch and apply a new one behind the opposite ear to avoid local skin irritation. Do not touch the patch during use, as pressure may cause hyoscine to seep out from the edges. If accidental contact occurs, wash your hands immediately.
Swimming, showering, or washing your hair will not affect the adhesion or effectiveness of the patch, provided it does not fall off during water exposure. Patches that have been used for less than 72 hours cannot be reused once removed.
The Scopoderm patch must never be cut, divided into smaller pieces, or modified in any way. The patch is a reservoir-based delivery system, and cutting it would destroy the controlled-release mechanism, potentially leading to an uncontrolled rapid release of the entire drug content through the damaged membrane. This could result in serious overdose effects.
Children (10 Years and Older)
Pediatric Dose (Age 10+)
Children aged 10 years and older may use Scopoderm at the same dosage as adults (one patch at a time). Scopoderm must not be used in children under 10 years of age due to limited clinical data in this population. Parental supervision during application and monitoring for side effects is recommended.
Elderly Patients
Elderly Dose
Elderly patients may use the standard adult dose (one patch). However, older adults may have an increased risk of side effects, particularly drowsiness, confusion, cognitive impairment, urinary retention, and dry mouth. A careful risk-benefit assessment by a healthcare provider is recommended before use.
Missed Dose
If you forget to apply the Scopoderm patch before travel, apply it as soon as you remember. However, be aware that the patch requires approximately 5–6 hours to reach effective therapeutic levels. Do not apply two patches simultaneously to compensate for a missed or late application. If you have already begun to experience motion sickness symptoms, oral medications such as antihistamines may provide faster relief while waiting for the patch to take effect.
Overdose
If too many patches are applied at the same time, an anticholinergic toxicity syndrome may develop. Early symptoms of overdose include restlessness, excitation, and confusion. At higher levels of overdose, symptoms may progress to disorientation, visual hallucinations, seizures, and in severe cases, coma and respiratory depression. The classic presentation of anticholinergic toxicity is often summarized by the clinical mnemonic: “blind as a bat (mydriasis), dry as a bone (anhidrosis), red as a beet (cutaneous vasodilation), mad as a hatter (delirium), hot as a hare (hyperthermia).”
In case of suspected overdose, remove all patches immediately and seek emergency medical attention. Note that some overdose symptoms may persist for up to 24 hours or longer after patch removal, because hyoscine continues to be absorbed from the skin depot at the application site and because the drug has a significant tissue distribution. Bring any remaining patches with you to the hospital to assist medical staff in determining the extent of exposure. Treatment is primarily supportive; in severe cases, physostigmine may be administered under medical supervision as a specific antidote for anticholinergic toxicity.
Withdrawal Effects After Stopping
In isolated cases — usually after several days of continuous use — discontinuation symptoms have been reported after removing the Scopoderm patch. These may include dizziness, nausea, vomiting, headache, and balance disturbances (vertigo). These symptoms are thought to reflect a rebound increase in cholinergic activity following withdrawal of the anticholinergic blockade. If you experience these symptoms, contact your healthcare provider. The risk of withdrawal effects may be minimized by using the patch for the shortest duration necessary.
What Are the Side Effects of Scopoderm?
Like all medications, Scopoderm can cause side effects, although not everyone who uses the patch will experience them. The anticholinergic mechanism of action of hyoscine is responsible for most of the observed adverse effects. Because the drug is delivered continuously through the skin, side effects tend to be milder and more gradual in onset compared with oral or injectable formulations. However, individual sensitivity varies considerably, and some patients may experience significant adverse reactions even at standard doses.
The following side effect frequency grid summarizes the known adverse reactions associated with Scopoderm, categorized by how commonly they occur:
Very Common
May affect more than 1 in 10 people
- Dry mouth (xerostomia) — the most frequently reported side effect; maintain good oral hygiene during use
- Drowsiness and sedation
- Dizziness
- Blurred near vision (accommodation impairment) and dilated pupils (mydriasis), sometimes affecting only one eye
- Difficulty focusing on near or distant objects
Common
May affect up to 1 in 10 people
- Eyelid irritation
- Skin irritation at the application site
Rare
May affect up to 1 in 1,000 people
- Difficulty urinating (urinary retention)
- Impaired memory or concentration
- Restlessness and agitation
- Disorientation and confusion
- Hallucinations (visual or auditory)
Very Rare
May affect up to 1 in 10,000 people
- Visual disturbances with increased intraocular pressure (possible signs of acute angle-closure glaucoma) — remove patch and seek immediate medical attention
- Generalized skin rash (allergic dermatitis)
Not Known
Frequency cannot be estimated from available data
- Restlessness and excessive involuntary movements
- Coordination abnormalities (ataxia)
- Headache
- Application site reactions: itching, redness, and burning sensation
Dry mouth is the most commonly reported adverse effect and is a direct consequence of the anticholinergic blockade of salivary gland secretion. It is important to maintain excellent oral hygiene while using Scopoderm, as prolonged dry mouth increases the risk of dental caries, gingival disease, and oral candidiasis (thrush). Sugar-free chewing gum, frequent sips of water, and saliva substitutes can help alleviate discomfort. Patients who wear contact lenses should be aware that reduced tear production due to the anticholinergic effect may cause dry, uncomfortable eyes.
Visual side effects deserve particular attention because they can be asymmetric — affecting only one eye if the active substance is inadvertently transferred from the fingers to one eye. This is why thorough handwashing after touching the patch is critically important. If you notice dilated pupils, blurred vision, or difficulty focusing, particularly if it affects only one eye, this is likely due to direct contact with hyoscine rather than a systemic effect, and it will resolve on its own within 24–48 hours.
Patients with epilepsy should be aware that an increased risk of seizures has been reported in a small number of cases. If you have a seizure disorder, discuss the risks and benefits of Scopoderm use with your neurologist before using the patch.
You experience sudden eye pain, severe headache, blurred vision with halos around lights, or eye redness while using Scopoderm. These may be signs of acute angle-closure glaucoma, which requires emergency treatment to prevent permanent vision loss. Remove the patch immediately and go to your nearest emergency department.
Side Effects After Stopping Scopoderm
After stopping treatment with Scopoderm, particularly after several days of continuous use, some patients have experienced withdrawal-like symptoms. These are rare but may include dizziness, nausea, vomiting, headache, and balance disturbances. These effects are thought to be caused by a rebound increase in cholinergic nervous system activity following the removal of anticholinergic blockade. Symptoms are generally mild and self-limiting, resolving within 24–72 hours without specific treatment. If symptoms are severe or persistent, contact your healthcare provider.
How Should You Store Scopoderm?
Proper storage of Scopoderm is essential to maintain the effectiveness and safety of the medication. The patches should be stored in their original sealed aluminum foil sachets until immediately before use. Exposure to air can cause the adhesive to dry out and the controlled-release membrane to degrade, potentially affecting drug delivery performance. Store the sealed sachets at a temperature below 25°C (77°F). Do not refrigerate or freeze the patches. Protect from excessive heat and direct sunlight.
Keep Scopoderm patches out of the sight and reach of children at all times. This applies to both unused patches in their sachets and used patches that have been removed. Used patches still contain a significant amount of residual hyoscine, and accidental exposure — particularly oral ingestion by a child — could result in serious anticholinergic toxicity. After removal, fold the used patch in half with the adhesive side facing inward so that the active surface is not exposed.
Do not use the patch after the expiry date printed on the carton and the individual sachet (after “EXP”). The expiry date refers to the last day of the stated month. Expired patches may have degraded drug content or compromised delivery systems and should not be used.
Do not dispose of used or unused patches in household waste or by flushing them down the toilet. The active pharmaceutical ingredient in the patch can contaminate water systems and harm the environment. Return unused or expired patches to your local pharmacy for safe disposal according to local pharmaceutical waste regulations.
What Does Scopoderm Contain?
Understanding the composition of Scopoderm can help patients identify the product correctly and be aware of any potential allergens in the formulation. Each transdermal patch contains the following:
Active Ingredient
Hyoscine (scopolamine) — 1.3 mg per patch. The drug is contained in a reservoir within the patch system and is delivered through the skin at a controlled rate of approximately 5 micrograms per hour. Of the total 1.3 mg content, approximately 1 mg is delivered over the 72-hour wearing period, with the remainder retained in the patch.
Inactive Ingredients (Excipients)
The Scopoderm transdermal system consists of multiple layers designed to control the rate of drug delivery through the skin:
- Aluminized polyester film — the outer backing layer that provides structural support and prevents drug loss through the outer surface
- Crospovidone — a polymer used in the drug reservoir matrix
- Isopropyl palmitate — a skin penetration enhancer that facilitates drug absorption
- Light mineral oil — a component of the reservoir formulation
- Liquid paraffin — helps maintain the patch matrix
- Polyisobutylene — the adhesive polymer that ensures the patch stays attached to the skin
- Ethylene-vinyl acetate copolymer — the rate-controlling membrane that regulates drug delivery
- Polyester — a structural component of the patch layers
Physical Description
The Scopoderm patch is a flat, round, reservoir-type transdermal therapeutic system approximately 1.8 cm in diameter. One side is beige (the outer surface visible when worn) and the other is silver-colored with a self-adhesive coating (the side that adheres to the skin). Before use, the adhesive surface is covered by an oversized clear square protective release liner that is removed immediately before application.
Scopoderm is available in the following pack sizes: cartons containing 2, 5, or 10 individually sealed aluminum foil sachets. Not all pack sizes may be marketed in every country.
Frequently Asked Questions About Scopoderm
Scopoderm and Transderm Scop are essentially the same product marketed under different brand names in different regions. Both contain 1.3 mg of hyoscine (scopolamine) in a transdermal patch designed to provide controlled drug delivery for up to 72 hours. Scopoderm is the brand name commonly used in Europe, while Transderm Scop is the brand name used primarily in the United States. The active ingredient, delivery mechanism, dosage, and clinical use are identical. The patches may differ slightly in their inactive ingredients and physical appearance, but they are therapeutically equivalent.
You can use Scopoderm while wearing glasses; the visual blurring caused by the medication is primarily an accommodation deficit that glasses do not correct, but it is generally mild. Contact lens wearers should be aware that hyoscine can reduce tear production, which may make lenses uncomfortable and increase the risk of corneal irritation. It is especially important to wash your hands thoroughly before handling contact lenses after touching the patch, as even trace amounts of hyoscine on the fingers can cause unilateral pupil dilation and near-vision impairment. Consider wearing glasses instead of contact lenses during the period you are using the patch.
For optimal protection, apply the Scopoderm patch the evening before your travel day. At minimum, the patch should be applied at least 5–6 hours before departure to allow sufficient time for the drug to be absorbed through the skin and reach effective plasma concentrations. The initial priming dose in the adhesive layer provides some early drug absorption, but full therapeutic levels are not achieved for several hours. Applying the patch well in advance of travel is especially important for situations where motion sickness onset may be rapid, such as boat travel in rough seas.
Yes, Scopoderm is considered one of the most effective single agents for preventing seasickness. Seasickness is the most common and often the most severe form of motion sickness, as the continuous and unpredictable multi-axis motion of a boat creates a powerful sensory conflict in the vestibular system. Hyoscine’s action on the vestibular nuclei makes it particularly effective against this type of motion stimulus. The transdermal patch is especially advantageous for sea travel because it provides continuous protection for up to 72 hours without the need for oral dosing, which would be unreliable if the patient is vomiting. It is widely used by cruise passengers, naval personnel, and recreational sailors.
No, you should never use more than one Scopoderm patch at a time. Using multiple patches simultaneously significantly increases the risk of anticholinergic overdose, which can cause serious symptoms including confusion, hallucinations, seizures, rapid heart rate, dangerously elevated body temperature, and in severe cases, coma. One patch delivers the appropriate therapeutic dose for motion sickness prevention. If one patch does not provide adequate relief, do not add additional patches — consult your healthcare provider about alternative or supplementary treatment options.
If you accidentally transfer hyoscine from the patch to your eye (which can happen if you touch the patch and then rub your eye), you may experience temporary dilation of the pupil (mydriasis) and blurred near vision in the affected eye. This is uncomfortable but not dangerous, and it typically resolves on its own within 24–48 hours. Rinse the affected eye gently with clean lukewarm water. Do not attempt to drive or perform tasks requiring precise near vision until the symptoms have fully resolved. Wearing sunglasses may help with light sensitivity caused by the dilated pupil. To prevent this from occurring, always wash your hands thoroughly with soap and water after applying, touching, or removing the patch.
References
- European Medicines Agency (EMA). Scopoderm Summary of Product Characteristics. Last updated 2025.
- U.S. Food and Drug Administration (FDA). Transderm Scop (scopolamine) Transdermal Therapeutic System – Prescribing Information. Revised 2024.
- British National Formulary (BNF). Hyoscine hydrobromide. National Institute for Health and Care Excellence (NICE), 2025.
- World Health Organization (WHO). Model List of Essential Medicines – 23rd List, 2023.
- Spinks A, Wasiak J. Scopolamine (hyoscine) for preventing and treating motion sickness. Cochrane Database of Systematic Reviews. 2011;(6):CD002851. doi:10.1002/14651858.CD002851.pub5
- Golding JF, Gresty MA. Pathophysiology and treatment of motion sickness. Current Opinion in Neurology. 2015;28(1):83–88.
- Brainard A, Gresham C. Prevention and treatment of motion sickness. American Family Physician. 2014;90(1):41–46.
- Nachum Z, Shupak A, Gordon CR. Transdermal scopolamine for prevention of motion sickness: clinical pharmacokinetics and therapeutic applications. Clinical Pharmacokinetics. 2006;45(6):543–566.
- Renner UD, Oertel R, Kirch W. Pharmacokinetics and pharmacodynamics in clinical use of scopolamine. Therapeutic Drug Monitoring. 2005;27(5):655–665.
- Priesol AJ. Motion sickness. UpToDate. Last updated 2025.
Editorial Team
This article has been written and reviewed by qualified medical professionals committed to providing accurate, evidence-based pharmaceutical information.
Medical Content
iMedic Medical Editorial Team – specialists in clinical pharmacology, otolaryngology, and evidence-based medicine with extensive experience in pharmaceutical information development.
Medical Review
iMedic Medical Review Board – independent panel of board-certified physicians who review all content according to EMA, FDA, BNF, and WHO guidelines.
Evidence Standards
Content follows the GRADE evidence framework. All clinical claims are supported by peer-reviewed research, systematic reviews, and official product information (SmPC/FDA label).
Editorial Independence
iMedic receives no funding from pharmaceutical companies. All content is produced independently without commercial influence or advertising sponsorship.